Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

279
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
279
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

385
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
385

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motor mapping to enable resections of peri-rolandic diffuse gliomas.

Journal of neuro-oncology·2026
Same author

Safety and feasibility of paired vagus nerve stimulation with rehabilitation for improving upper extremity function in people with cervical spinal cord injury: a pilot randomized controlled trial.

Frontiers in rehabilitation sciences·2026
Same author

Microelectrode arrays enable directional stereo-EEG during kainate-mediated seizures.

bioRxiv : the preprint server for biology·2026
Same author

Stereotactic Radiosurgery Versus Reoperation in Small Surgically Accessible Recurrent Glioblastoma.

Neurosurgery·2026
Same author

Prognostic Validation of the RANO-Resect Classification and Non-Contrast-Enhancing Tumor Resection: A Meta-Science Study in Glioblastoma Surgery.

Neurosurgery·2026
Same author

Laser interstitial thermal therapy versus stereotactic radiosurgery for first-time treatment of recurrent glioblastoma: a retrospective single-center study.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Oct 2, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K

Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents.

Runjhun Tandon1, Vijay Luxami2, Nitin Tandon1

  • 1School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara 144411, India.

Bioorganic Chemistry
|February 24, 2022
PubMed
Summary

Naphthalimide derivatives show potent anticancer activity by intercalating with DNA. Modifying these compounds with various chemical groups enhances their cytotoxic properties and selectivity against cancer cells.

Keywords:
1,8-Naphthalimide derivativesAntiproliferative activityCytotoxic propertiesHuman cancer cell linesHypochromismIntercalation

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.9K

Related Experiment Videos

Last Updated: Oct 2, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.9K

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Pharmacology

Background:

  • The 1,8-naphthalimide scaffold is recognized for its DNA intercalating ability and diverse biological activities.
  • Naphthalimide derivatives are actively investigated as potential anticancer agents due to their broad-spectrum efficacy.
  • Some derivatives exhibit superior anticancer activity and selectivity compared to established drugs like cisplatin.

Purpose of the Study:

  • To explore the impact of structural modifications on the anticancer properties of 1,8-naphthalimide derivatives.
  • To investigate the structure-activity relationships of naphthalimide derivatives with polyamine, thiourea, benzothiazole, and benzimidazole moieties.
  • To evaluate the influence of metal complexes and bis-naphthalimides on the cytotoxic profiles of these compounds.

Main Methods:

  • Synthesis and characterization of novel 1,8-naphthalimide derivatives.
  • In vitro evaluation of cytotoxic activity against a panel of cancer cell lines.
  • Structure-activity relationship (SAR) analysis to correlate structural features with anticancer efficacy.

Main Results:

  • Various substitutions at the 1,8-naphthalimide ring significantly modulated anticancer properties.
  • Certain derivatives demonstrated enhanced potency and selectivity against specific cancer cell lines.
  • Metal complexes and bis-naphthalimides showed promising cytotoxic effects.

Conclusions:

  • Structural modifications of 1,8-naphthalimides offer a promising strategy for developing novel anticancer agents.
  • Understanding SAR is crucial for designing naphthalimide derivatives with improved drug profiles.
  • This review provides valuable insights for researchers in designing targeted anticancer therapies.